Skystar Bio-pharmaceutical Co. (fka SKBI)

[236T568]

Good, point

the auditor was probably satisfied with just reviewing the bank statements provided by the company for the 10Q's but for the 2014 10K, it was a different story, as the auditor insisted on verifying the bank statements provided by the company with the bank itself.

hence the problem here

oops!


Look for RESTATEMENT of financials for the 2014 10Q's - all 3 of them

I did not see the issuer file 8K, Item 4.02. Secondly, that is not how an audit is conducted. While the issuer provides bank statements and schedules, the issuer is to request from the bank to send directly to the auditor verification of the same. This is the exact reason, to prohibit falsifying bank statements. This excuse is wrong and a cover up of something else.

I doubt the bank falsified anything on behalf of the issuer.